Intravenous adenosine for refractory pulmonary hypertension in a low-weight premature newborn: A potential new drug for rescue therapy

Authors:
  • CTCécile Tissot
    Cécile Tissot
  • PRPeter C Rimensberger
    Peter C Rimensberger
  • APAline Prina-Rousso
    Aline Prina-Rousso
  • YAYacine Aggoun
    Yacine Aggoun
  • MBMichel Berner
    Michel Berner
  • MBMaurice Beghetti
    Maurice Beghetti
  • ECEduardo Da Cruz
    Eduardo Da Cruz

Abstract
To use intravenous adenosine as a rescue therapy for neonatal refractory pulmonary hypertension in a low-weight premature infant. We report the successful use of a continuous intravenous adenosine infusion in a 1150-g premature baby with severe persistent pulmonary hypertension, refractory to classic management with high-frequency oscillatory ventilation, oxygen therapy and inhaled nitric oxide. Adenosine infusion had a dramatic effect allowing for a rapid weaning of oxygen, ventilatory variables, and nitric oxide. Although experience with continuous adenosine infusion is still at an early stage, it might be worth considering its administration as a rescue therapy or even as an alternative to extracorporeal membrane oxygenation.

This publication has 12 references indexed in Scilit: